DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Marriott Wardman Park Hotel

2020 年 01 月 27 日 7:00 上午 - 2020 年 01 月 29 日 4:15 下午

2660 Woodley Road, NW, , Washington, DC 20008 , USA

Pharmacovigilance and Risk Management Strategies Conference

Session 5: Hot Topics – Handling Emerging Trends in Pharmacovigilance

Session Chair(s)

Barbara  Morollo, RN

Barbara Morollo, RN

Head, Pharmacovigilance

Corbus Pharmaceuticals, United States

Catherine  Baldridge, MSc

Catherine Baldridge, MSc

Head of Safety

Fusion Pharmaceuticals, United States

This session will explore three hot topics and emerging trends in pharmacovigilance which include spanning discussions regarding predictive safety using translational data and non-clinical data for predicting ADRs, the impact of cannabinoids as therapeutics and research into the endocannabinoid system.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the technology and factors that contribute to the ability to predict an adverse events or adverse event in a specific population
  • Identify the unique regulatory challenges surrounding cannabis and studying therapeutic benefits in investigational research

Speaker(s)

Barbara  Morollo, RN

Cannabinoids as Therapeutics

Barbara Morollo, RN

Corbus Pharmaceuticals, United States

Head, Pharmacovigilance

Glenn  Carroll, MBA

Speaker

Glenn Carroll, MBA

Deloitte, United States

Principal

Sarah  Vaughan

Yellow Card Biobank

Sarah Vaughan

Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom

Head of Vigilance Operations

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。